In bladder cancer, p53 gene mutations are generally believed to indicate invasive bladder cancer and disease progression and to be useful as chemotherapy response markers, although some studies have come to contradictory conclusions (Schmitz-Drager et al. 2000; Sarkis et al. 1995; Sengelov et al. 1997). The gene discussed is TP53; the disease is urinary bladder cancer.